Beta Bionics, Inc. Common Stock (BBNX) valuation · rev $100.3M
Beta Bionics, Inc. Common Stock (BBNX) rev $100.3M.
| Metric | Value |
|---|---|
| Market cap | $640.8M |
| Revenue | $100.3M |
| P/S | 6.4 |
| P/B | 2.4 |
BBNX valuation FAQ
What is BBNX's market cap?
Beta Bionics, Inc. Common Stock (BBNX) market cap is $640.8M on the latest cached fundamentals snapshot.
What is BBNX's latest revenue?
Latest cached Beta Bionics, Inc. Common Stock (BBNX) revenue was $100.3M. Statements: https://lician.com/financials/bbnx
What is BBNX's price-to-sales ratio?
Beta Bionics, Inc. Common Stock (BBNX) price-to-sales (P/S) is 6.4, cached market cap $640.8M divided by revenue $100.3M.
What is BBNX's price-to-book ratio?
Beta Bionics, Inc. Common Stock (BBNX) price-to-book (P/B) is 2.4 on the latest cached fundamentals snapshot.
How many BBNX valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Beta Bionics, Inc. Common Stock (BBNX): Market cap, Revenue, P/S, and P/B.
Where is BBNX valuation listed?
Cached valuation multiples for Beta Bionics, Inc. Common Stock (BBNX) are listed at https://lician.com/valuation/bbnx.
Not investment advice. Cached rows, not a live tape.